Furoxim 125 mg – Dry Powder for Oral Suspension

Composition

Each 5 mL of the oral suspension contains:

• Cefuroxime ( as axetil ): 125 mg.
• Excipient: S.Q. for 5 mL.

Indications

Furoxim for oral suspension is indicated for the treatment of pediatric patients 3 months to 12 years of age with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below.

• Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.
• Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta-lactamase producing strains). Moraxella catarrhalis (including beta-lactamase-producing strains) or Streptococcus pyogenes.
• Impetigo caused by Staphylococcus aureus (including beta-lactamase-producing strains) or Streptococcus pyogenes.

Dosage & Administration

Furoxim for oral suspension may be administered to infants and children ranging in age from 3 months to 12 years, according to dosages in the following table (Must be administered with food. Sake well each time before using):

Infants and children (3 months to 12 years):

Pharyngitis/tonsillitis:

20 mg/kg/day in divided two doses, for 10 days. Maximum dose 500 mg/day.

Acute otitis media:

30 mg/kg/day in divided two doses, for 10 days. Maximum dose 1000 mg/day.

Impetigo:

30 mg/kg/day in divided two doses, for 10 days. Maximum dose 1000 mg/day.

Directions for Mixing Furoxim for Oral Suspension:

Prepare a suspension at the time of dispensing as follows:

• Add 37 ml to the dry powder in Furoxim – 125 mg, and 35 ml to the dry powder in Furoxim – 250 mg.

• Shake the bottle to loosen the powder.
• Reconstituted suspension should be stored between 2˚ and 25˚ C (either in the refrigerator or at room temperature), for 10 days only.